Simultaneous targeting of mitochondria and monocytes enhances neuroprotection against ischemia–reperfusion injury

Abstract Ischemia–reperfusion injury impairs the efficacy of reperfusion therapy after ischemic stroke. Cyclophilin D (CypD)-mediated openings of mitochondrial permeability transition pore (mPTP) and subsequent monocyte-mediated inflammation are considered as major mechanisms of reperfusion injury....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Arihide Okahara, Jun-ichiro Koga, Tetsuya Matoba, Masaki Fujiwara, Masaki Tokutome, Gentaro Ikeda, Kaku Nakano, Masaki Tachibana, Tetsuro Ago, Takanari Kitazono, Hiroyuki Tsutsui, Kensuke Egashira
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/929409dd3f8a48648a7dd82691a4b1ce
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:929409dd3f8a48648a7dd82691a4b1ce
record_format dspace
spelling oai:doaj.org-article:929409dd3f8a48648a7dd82691a4b1ce2021-12-02T19:09:30ZSimultaneous targeting of mitochondria and monocytes enhances neuroprotection against ischemia–reperfusion injury10.1038/s41598-020-71326-x2045-2322https://doaj.org/article/929409dd3f8a48648a7dd82691a4b1ce2020-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-71326-xhttps://doaj.org/toc/2045-2322Abstract Ischemia–reperfusion injury impairs the efficacy of reperfusion therapy after ischemic stroke. Cyclophilin D (CypD)-mediated openings of mitochondrial permeability transition pore (mPTP) and subsequent monocyte-mediated inflammation are considered as major mechanisms of reperfusion injury. However, no medical therapies are currently available. Therefore, we have tested a hypothesis that simultaneous targeting of mPTP and inflammation confers substantial neuroprotection after cerebral ischemia–reperfusion. To address this point, we prepared CypD knockout mice, C–C chemokine receptor 2 (CCR2) knockout mice and CypD/CCR2 double knockout mice. These mice were subjected to 60 min transient cerebral ischemia by occluding middle cerebral arteries. Neurological deficits evaluated 3 days after reperfusion were significantly attenuated in CypD/CCR2 double knockout mice as compared to wild-type mice and other single knockout mice. Then, we have prepared polymeric nanoparticles containing cyclosporine A (CsA-NPs) and pitavastatin (Pitava-NPs), targeting mPTP opening and inflammation, respectively. Simultaneous administration of CsA-NP and Pitava-NP at the time of reperfusion also decreased infarct size and attenuated neurological deficits as compared to control nanoparticles and single administration of CsA-NPs or Pitava-NPs. These results indicate that simultaneous targeting of the mPTP opening and monocyte-mediated inflammation could be a novel strategy for better neurological outcomes in patients with ischemic stroke.Arihide OkaharaJun-ichiro KogaTetsuya MatobaMasaki FujiwaraMasaki TokutomeGentaro IkedaKaku NakanoMasaki TachibanaTetsuro AgoTakanari KitazonoHiroyuki TsutsuiKensuke EgashiraNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-14 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Arihide Okahara
Jun-ichiro Koga
Tetsuya Matoba
Masaki Fujiwara
Masaki Tokutome
Gentaro Ikeda
Kaku Nakano
Masaki Tachibana
Tetsuro Ago
Takanari Kitazono
Hiroyuki Tsutsui
Kensuke Egashira
Simultaneous targeting of mitochondria and monocytes enhances neuroprotection against ischemia–reperfusion injury
description Abstract Ischemia–reperfusion injury impairs the efficacy of reperfusion therapy after ischemic stroke. Cyclophilin D (CypD)-mediated openings of mitochondrial permeability transition pore (mPTP) and subsequent monocyte-mediated inflammation are considered as major mechanisms of reperfusion injury. However, no medical therapies are currently available. Therefore, we have tested a hypothesis that simultaneous targeting of mPTP and inflammation confers substantial neuroprotection after cerebral ischemia–reperfusion. To address this point, we prepared CypD knockout mice, C–C chemokine receptor 2 (CCR2) knockout mice and CypD/CCR2 double knockout mice. These mice were subjected to 60 min transient cerebral ischemia by occluding middle cerebral arteries. Neurological deficits evaluated 3 days after reperfusion were significantly attenuated in CypD/CCR2 double knockout mice as compared to wild-type mice and other single knockout mice. Then, we have prepared polymeric nanoparticles containing cyclosporine A (CsA-NPs) and pitavastatin (Pitava-NPs), targeting mPTP opening and inflammation, respectively. Simultaneous administration of CsA-NP and Pitava-NP at the time of reperfusion also decreased infarct size and attenuated neurological deficits as compared to control nanoparticles and single administration of CsA-NPs or Pitava-NPs. These results indicate that simultaneous targeting of the mPTP opening and monocyte-mediated inflammation could be a novel strategy for better neurological outcomes in patients with ischemic stroke.
format article
author Arihide Okahara
Jun-ichiro Koga
Tetsuya Matoba
Masaki Fujiwara
Masaki Tokutome
Gentaro Ikeda
Kaku Nakano
Masaki Tachibana
Tetsuro Ago
Takanari Kitazono
Hiroyuki Tsutsui
Kensuke Egashira
author_facet Arihide Okahara
Jun-ichiro Koga
Tetsuya Matoba
Masaki Fujiwara
Masaki Tokutome
Gentaro Ikeda
Kaku Nakano
Masaki Tachibana
Tetsuro Ago
Takanari Kitazono
Hiroyuki Tsutsui
Kensuke Egashira
author_sort Arihide Okahara
title Simultaneous targeting of mitochondria and monocytes enhances neuroprotection against ischemia–reperfusion injury
title_short Simultaneous targeting of mitochondria and monocytes enhances neuroprotection against ischemia–reperfusion injury
title_full Simultaneous targeting of mitochondria and monocytes enhances neuroprotection against ischemia–reperfusion injury
title_fullStr Simultaneous targeting of mitochondria and monocytes enhances neuroprotection against ischemia–reperfusion injury
title_full_unstemmed Simultaneous targeting of mitochondria and monocytes enhances neuroprotection against ischemia–reperfusion injury
title_sort simultaneous targeting of mitochondria and monocytes enhances neuroprotection against ischemia–reperfusion injury
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/929409dd3f8a48648a7dd82691a4b1ce
work_keys_str_mv AT arihideokahara simultaneoustargetingofmitochondriaandmonocytesenhancesneuroprotectionagainstischemiareperfusioninjury
AT junichirokoga simultaneoustargetingofmitochondriaandmonocytesenhancesneuroprotectionagainstischemiareperfusioninjury
AT tetsuyamatoba simultaneoustargetingofmitochondriaandmonocytesenhancesneuroprotectionagainstischemiareperfusioninjury
AT masakifujiwara simultaneoustargetingofmitochondriaandmonocytesenhancesneuroprotectionagainstischemiareperfusioninjury
AT masakitokutome simultaneoustargetingofmitochondriaandmonocytesenhancesneuroprotectionagainstischemiareperfusioninjury
AT gentaroikeda simultaneoustargetingofmitochondriaandmonocytesenhancesneuroprotectionagainstischemiareperfusioninjury
AT kakunakano simultaneoustargetingofmitochondriaandmonocytesenhancesneuroprotectionagainstischemiareperfusioninjury
AT masakitachibana simultaneoustargetingofmitochondriaandmonocytesenhancesneuroprotectionagainstischemiareperfusioninjury
AT tetsuroago simultaneoustargetingofmitochondriaandmonocytesenhancesneuroprotectionagainstischemiareperfusioninjury
AT takanarikitazono simultaneoustargetingofmitochondriaandmonocytesenhancesneuroprotectionagainstischemiareperfusioninjury
AT hiroyukitsutsui simultaneoustargetingofmitochondriaandmonocytesenhancesneuroprotectionagainstischemiareperfusioninjury
AT kensukeegashira simultaneoustargetingofmitochondriaandmonocytesenhancesneuroprotectionagainstischemiareperfusioninjury
_version_ 1718377102730854400